Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study

Background and objective Moyamoya disease (MMD) is an increasingly recognised cause of stroke, mainly described in East Asia. China is the largest nation in Asia, but few studies reported the epidemiology of MMD, especially at a national level. We aimed to estimate the incidence and prevalence of MM...

Full description

Bibliographic Details
Main Authors: Lu Chen, Pei Gao, Siyan Zhan, Shengfeng Wang, Jingnan Feng, Guozhen Liu, Jinxi Wang, Zheng Yang, Yixin Sun, Guoyu Zhou, Qingliang Wang, Junyou Yu, Xiwang Yang
Format: Article
Language:English
Published: BMJ Publishing Group
Series:Stroke and Vascular Neurology
Online Access:https://svn.bmj.com/content/early/2021/05/03/svn-2021-000909.full
id doaj-f5f9f57762a245eb98e355cd6964903a
record_format Article
spelling doaj-f5f9f57762a245eb98e355cd6964903a2021-05-05T14:30:03ZengBMJ Publishing GroupStroke and Vascular Neurology2059-869610.1136/svn-2021-000909Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort studyLu Chen0Pei Gao1Siyan Zhan2Shengfeng Wang3Jingnan Feng4Guozhen Liu5Jinxi Wang6Zheng Yang7Yixin Sun8Guoyu Zhou9Qingliang Wang10Junyou Yu11Xiwang Yang12Department of Neurology, Peking University Third Hospital, Beijing, ChinaDepartment of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Centre, Beijing, ChinaDepartment of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Centre, Beijing, ChinaDepartment of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Centre, Beijing, ChinaDepartment of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Centre, Beijing, ChinaPeking University Health Information Technology Co. Ltd, Beijing, ChinaBeijing Healthcom Data Technology Co. Ltd, Beijing, ChinaDepartment of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Centre, Beijing, ChinaDepartment of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Centre, Beijing, ChinaDepartment of Geriatric Neurology, Qilu Hospital of Shandong University, Jinan, ChinaDepartment of Medical Affairs, Qilu Hospital of Shandong University, Jinan, ChinaDepartment of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Centre, Beijing, ChinaDepartment of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Centre, Beijing, ChinaBackground and objective Moyamoya disease (MMD) is an increasingly recognised cause of stroke, mainly described in East Asia. China is the largest nation in Asia, but few studies reported the epidemiology of MMD, especially at a national level. We aimed to estimate the incidence and prevalence of MMD in China.Methods We performed a population-based study using data from the national databases of Urban Basic Medical Insurance between 2013 and 2016, covering approximately 0.50 billion individuals. MMD cases were identified by diagnostic code (International Classification of Diseases, 10th Revision I67.5) or related diagnostic text.Results A total of 1987 MMD patients (mean age 44.45±14.30 years, female-to-male ratio 1.12) were identified, representing a national crude incidence of 0.59 (95% CI: 0.49 to 0.68) and a prevalence of 1.01 (95% CI: 0.81 to 1.21) per 100 000 person-years in 2016. Rates were higher in females than in males for the incidence (0.66 vs 0.52) and prevalence (1.05 vs 0.90). And the age-specific rates showed a bimodal distribution, with the highest peak in middle-aged group and the second peak in child group.Conclusions Our results confirm that MMD is relatively common in East Asians, but the rates in China were lower than those in other East Asian countries such as Japan and Korea. The unique epidemiological features, including a relatively weak female predominance and a shift in the highest peak of incidence from children to adults, revealed new sight into MMD. Further research is expected to explore the potential pathogenesis of MMD.https://svn.bmj.com/content/early/2021/05/03/svn-2021-000909.full
collection DOAJ
language English
format Article
sources DOAJ
author Lu Chen
Pei Gao
Siyan Zhan
Shengfeng Wang
Jingnan Feng
Guozhen Liu
Jinxi Wang
Zheng Yang
Yixin Sun
Guoyu Zhou
Qingliang Wang
Junyou Yu
Xiwang Yang
spellingShingle Lu Chen
Pei Gao
Siyan Zhan
Shengfeng Wang
Jingnan Feng
Guozhen Liu
Jinxi Wang
Zheng Yang
Yixin Sun
Guoyu Zhou
Qingliang Wang
Junyou Yu
Xiwang Yang
Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study
Stroke and Vascular Neurology
author_facet Lu Chen
Pei Gao
Siyan Zhan
Shengfeng Wang
Jingnan Feng
Guozhen Liu
Jinxi Wang
Zheng Yang
Yixin Sun
Guoyu Zhou
Qingliang Wang
Junyou Yu
Xiwang Yang
author_sort Lu Chen
title Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study
title_short Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study
title_full Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study
title_fullStr Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study
title_full_unstemmed Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study
title_sort incidence and prevalence of moyamoya disease in urban china: a nationwide retrospective cohort study
publisher BMJ Publishing Group
series Stroke and Vascular Neurology
issn 2059-8696
description Background and objective Moyamoya disease (MMD) is an increasingly recognised cause of stroke, mainly described in East Asia. China is the largest nation in Asia, but few studies reported the epidemiology of MMD, especially at a national level. We aimed to estimate the incidence and prevalence of MMD in China.Methods We performed a population-based study using data from the national databases of Urban Basic Medical Insurance between 2013 and 2016, covering approximately 0.50 billion individuals. MMD cases were identified by diagnostic code (International Classification of Diseases, 10th Revision I67.5) or related diagnostic text.Results A total of 1987 MMD patients (mean age 44.45±14.30 years, female-to-male ratio 1.12) were identified, representing a national crude incidence of 0.59 (95% CI: 0.49 to 0.68) and a prevalence of 1.01 (95% CI: 0.81 to 1.21) per 100 000 person-years in 2016. Rates were higher in females than in males for the incidence (0.66 vs 0.52) and prevalence (1.05 vs 0.90). And the age-specific rates showed a bimodal distribution, with the highest peak in middle-aged group and the second peak in child group.Conclusions Our results confirm that MMD is relatively common in East Asians, but the rates in China were lower than those in other East Asian countries such as Japan and Korea. The unique epidemiological features, including a relatively weak female predominance and a shift in the highest peak of incidence from children to adults, revealed new sight into MMD. Further research is expected to explore the potential pathogenesis of MMD.
url https://svn.bmj.com/content/early/2021/05/03/svn-2021-000909.full
work_keys_str_mv AT luchen incidenceandprevalenceofmoyamoyadiseaseinurbanchinaanationwideretrospectivecohortstudy
AT peigao incidenceandprevalenceofmoyamoyadiseaseinurbanchinaanationwideretrospectivecohortstudy
AT siyanzhan incidenceandprevalenceofmoyamoyadiseaseinurbanchinaanationwideretrospectivecohortstudy
AT shengfengwang incidenceandprevalenceofmoyamoyadiseaseinurbanchinaanationwideretrospectivecohortstudy
AT jingnanfeng incidenceandprevalenceofmoyamoyadiseaseinurbanchinaanationwideretrospectivecohortstudy
AT guozhenliu incidenceandprevalenceofmoyamoyadiseaseinurbanchinaanationwideretrospectivecohortstudy
AT jinxiwang incidenceandprevalenceofmoyamoyadiseaseinurbanchinaanationwideretrospectivecohortstudy
AT zhengyang incidenceandprevalenceofmoyamoyadiseaseinurbanchinaanationwideretrospectivecohortstudy
AT yixinsun incidenceandprevalenceofmoyamoyadiseaseinurbanchinaanationwideretrospectivecohortstudy
AT guoyuzhou incidenceandprevalenceofmoyamoyadiseaseinurbanchinaanationwideretrospectivecohortstudy
AT qingliangwang incidenceandprevalenceofmoyamoyadiseaseinurbanchinaanationwideretrospectivecohortstudy
AT junyouyu incidenceandprevalenceofmoyamoyadiseaseinurbanchinaanationwideretrospectivecohortstudy
AT xiwangyang incidenceandprevalenceofmoyamoyadiseaseinurbanchinaanationwideretrospectivecohortstudy
_version_ 1721460085078622208